Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention
Clinical trial NCT02848326 · COMPLETED
Trial details
- NCT number
- NCT02848326
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-06
- Primary completion
- 2018-04-02
- Enrollment
- 834
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.